Ouro Fino Saúde Animal Participações S.A (OFSA3) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.166x

Based on the latest financial reports, Ouro Fino Saúde Animal Participações S.A (OFSA3) has a cash flow conversion efficiency ratio of 0.166x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (R$135.27 Million ≈ $26.54 Million USD) by net assets (R$816.49 Million ≈ $160.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Ouro Fino Saúde Animal Participações S.A (OFSA3) market capitalisation for the company's overall valuation and market capitalisation.

Ouro Fino Saúde Animal Participações S.A - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Ouro Fino Saúde Animal Participações S.A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Ouro Fino Saúde Animal Participações S.A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ouro Fino Saúde Animal Participações S.A ranked by their cash flow conversion efficiency. Explore earnings quality score of Ouro Fino Saúde Animal Participações S.A to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
LINAS AGRO GROUP EO 029
F:YG4
0.046x
Hyundai Motor S3 Pref
KO:005389
0.011x
Standard Biotools Inc
NASDAQ:LAB
-0.019x
What's Cooking Group NV/SA
BR:WHATS
0.010x
Langfang Development Co Ltd
SHG:600149
-0.013x
Telecomunicações Brasileiras S.A. - TELEBRÁS
SA:TELB3
-0.032x
Pengana Private Equity Trust
AU:PE1
0.006x
Colonial Coal International Corp
V:CAD
-0.023x

Annual Cash Flow Conversion Efficiency for Ouro Fino Saúde Animal Participações S.A (2011–2025)

The table below shows the annual cash flow conversion efficiency of Ouro Fino Saúde Animal Participações S.A from 2011 to 2025. View Ouro Fino Saúde Animal Participações S.A (OFSA3) share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 R$796.86 Million
≈ $156.36 Million
R$99.91 Million
≈ $19.60 Million
0.125x +28.27%
2024-12-31 R$756.40 Million
≈ $148.42 Million
R$73.94 Million
≈ $14.51 Million
0.098x -64.59%
2023-12-31 R$689.39 Million
≈ $135.27 Million
R$190.30 Million
≈ $37.34 Million
0.276x +126.76%
2022-12-31 R$735.95 Million
≈ $144.41 Million
R$89.59 Million
≈ $17.58 Million
0.122x +67.93%
2021-12-31 R$641.45 Million
≈ $125.86 Million
R$46.50 Million
≈ $9.12 Million
0.072x -63.68%
2020-12-31 R$560.78 Million
≈ $110.03 Million
R$111.94 Million
≈ $21.96 Million
0.200x +74.32%
2019-12-31 R$492.45 Million
≈ $96.63 Million
R$56.39 Million
≈ $11.06 Million
0.115x +21.96%
2018-12-31 R$455.94 Million
≈ $89.46 Million
R$42.81 Million
≈ $8.40 Million
0.094x -61.70%
2017-12-31 R$405.88 Million
≈ $79.64 Million
R$99.50 Million
≈ $19.52 Million
0.245x +118.41%
2016-12-31 R$376.33 Million
≈ $73.84 Million
R$42.24 Million
≈ $8.29 Million
0.112x +175.25%
2015-12-31 R$380.31 Million
≈ $74.62 Million
R$15.51 Million
≈ $3.04 Million
0.041x +1478.41%
2014-12-31 R$330.16 Million
≈ $64.78 Million
R$853.00K
≈ $167.37K
0.003x -98.38%
2013-12-31 R$209.42 Million
≈ $41.09 Million
R$33.45 Million
≈ $6.56 Million
0.160x -6.07%
2012-12-31 R$194.84 Million
≈ $38.23 Million
R$33.13 Million
≈ $6.50 Million
0.170x +114.04%
2011-12-31 R$177.44 Million
≈ $34.82 Million
R$14.10 Million
≈ $2.77 Million
0.079x --

About Ouro Fino Saúde Animal Participações S.A

SA:OFSA3 Brazil Drug Manufacturers - Specialty & Generic
Market Cap
$270.93 Million
R$1.38 Billion BRL
Market Cap Rank
#15369 Global
#148 in Brazil
Share Price
R$25.68
Change (1 day)
-3.82%
52-Week Range
R$20.90 - R$33.78
All Time High
R$40.76
About

Ouro Fino Saúde Animal Participações S.A., together with its subsidiaries, engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil. The company operates through three segments: Production Animals; Companion Animals; and International Operations. It manufactures and trades in medicines, including an… Read more